Exploratory Clinical Study of TJ-83 on Anxiety in Patients with Irritable Bowel Syndrome

Exploratory Clinical Study of TJ-83 on Anxiety in Patients with Irritable Bowel Syndrome - (Brief Title: SWORD-C)

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031559

Enrollment

Registered

2018-04-01

Start date

2018-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

irritable bowel syndrome (IBS)

Interventions

standard treatment standard treatment + TJ-83

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Rome IV

Exclusion criteria

Exclusion criteria: cancer IBD state after big surgery psychiatric disorders

Design outcomes

Primary

Measure	Time frame
State-Trait Anxiety Inventory (STAI) 12 weeks later after the baseline	—

Secondary

Measure	Time frame
IBS-QOL quantitative GI symptoms Insomnia Severity Index (ISI)	—

Countries

Japan

Contacts

Public ContactTomotaka Shoji, MD

Tohoku University Hospital Department of Psychosomatic Medicine

tshoji@hosp.tohoku.ac.jp022-717-7327

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026